New program aims to protect liver patients from dangerous painkiller side effects during surgery
NCT ID NCT07249294
First seen Jan 07, 2026 · Last updated May 08, 2026 · Updated 17 times
Summary
This study tests a hospital program to stop using NSAIDs and metamizole (common painkillers) in people with advanced chronic liver disease who need major surgery. These drugs are risky for these patients because they can cause kidney damage, fluid buildup, and bleeding. The program involves 84 adults and tracks how often these drugs are prescribed and whether complications like kidney injury or bleeding occur.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PORTAL HYPERTENSION RELATED TO CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital del Mar
Barcelona, 08003, Spain
Conditions
Explore the condition pages connected to this study.